Skip to main content
letter
. 2021 Feb 3;82(5):e28–e30. doi: 10.1016/j.jinf.2021.01.023

Fig. 1.

Fig. 1:

Anti S antibody persistence overtime. ○ mean/outliers of Anti-S antibody titres at T1 by severity groups; + mean/outliers of Anti-S antibody titres at T2 by severity groups; x mean/outliers of Anti-S antibody titres at T3 by severity groups.